Navigation Links
Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
Date:4/9/2008

relationships with employees, licensees, other business partners or governmental entities; other business effects, including the effects of industry, economic or political conditions outside of Millennium or Takeda's control; transaction costs; actual or contingent liabilities; and other risks and uncertainties discussed in documents filed with the U.S. Securities and Exchange Commission by Millennium, as well as the tender offer documents to be filed by Mahogany Acquisition Corp. and the Solicitation/Recommendation Statement to be filed by Millennium. Neither Millennium nor Takeda undertakes any obligation to update any forward-looking statements as a result of new information, future developments or otherwise.

Additional Information

The tender offer for the outstanding common stock of Millennium referred to in this press release has not yet commenced. This press release is neither an offer to purchase nor a solicitation of an offer to sell any securities. The solicitation and the offer to buy shares of Millennium common stock will be made pursuant to an offer to purchase and related materials that Mahogany Acquisition Corp. intends to file with the U.S. Securities and Exchange Commission. At the time the tender offer is commenced, Mahogany Acquisition Corp. will file a Tender Offer Statement on Schedule TO with the U.S. Securities and Exchange Commission, and thereafter Millennium will file a Solicitation/Recommendation Statement on Schedule 14D-9 with respect to the tender offer. THE TENDER OFFER STATEMENT (INCLUDING AN OFFER TO PURCHASE, A RELATED LETTER OF TRANSMITTAL AND OTHER OFFER DOCUMENTS) AND THE SOLICITATION/RECOMMENDATION STATEMENT WILL CONTAIN IMPORTANT INFORMATION THAT SHOULD BE READ CAREFULLY AND CONSIDERED BEFORE ANY DECISION IS MADE WITH RESPECT TO THE TENDER OFFER. These materials will be sent free of charge to all stockholders of Millennium. In addition, all of these materials (and all other materials filed by Millennium with the U.
'/>"/>

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. PPD Confirms Takedas NDA Filing of Alogliptin with U.S. Food and Drug Administration
2. Affymax(R) and Takeda Recognized for Innovative Global Agreement to Develop and Commercialize Hematide(TM) for Anemia
3. Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
4. VWR International, LLC Acquires Jencons (Scientific) Ltd, UK
5. Aida Pharmaceuticals, Inc. Acquires High-Level Research Institute in the Peoples Republic of China
6. Aida Acquires High-Level Research Institute in China
7. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
8. China Aoxing Pharmaceutical Company Signed Definitive Acquisition Agreement to Acquire Shijiazhuang Lerentang Pharmaceutical Company, Ltd.
9. Immucor To Acquire BioArray Solutions Ltd.
10. Mindray to Acquire Datascopes Patient Monitoring Business for US$202 million
11. Elsevier Acquires Windhover Information Inc., a Healthcare Business Intelligence Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... have observed the "hot electron" effect in a solar ... elusive charges using ultra-thin solar cells, opening a potential ... in the current online edition of Applied Physics ... cells, it generates free electrons in a range of ... the electrons must reach the bottom of the conduction ...
(Date:12/11/2009)... Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ONCY ) ("Oncolytics" ... Dr. Alan Warrander to the role of Senior ... "Dr. Warrander will be responsible for the execution ... Dr. Brad Thompson, President and CEO of Oncolytics. ... a Phase 3 trial examining REOLYSIN in combination ...
(Date:12/10/2009)... National Institutes of Health (NIH), awarded a $2.18 million grant ... non-invasive, passive diffusion-based treatment for severe, non-infectious uveitis. ... ... (PRWEB) December 10, 2009 -- The National Eye Institute (NEI), ... a $2.18 million grant to Aciont Inc. to help fund ...
(Date:12/10/2009)... China Biologic,Products, Inc. (Nasdaq: CBPO ) ("China ... biopharmaceutical companies in China, today announced,that the Company,s ... at the,NASDAQ MarketSite in New York City at ... China Biologic,s common stock ... 2, 2009, under the ticker symbol "CBPO." , ...
Breaking Biology Technology:Elusive 'hot' electrons captured in ultra-thin solar cells 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3China Biologic Products to Ring NASDAQ Opening Bell 2China Biologic Products to Ring NASDAQ Opening Bell 3
... of Magainins, the first of a new class of anti-infectives, ... advise Company on pexiganan ... Bulletin Board: MACM) today announced that following its,acquisition of rights ... Board. Dr. Zasloff discovered magainins in,the skin of the African ...
... From a Separate Study Also Show Minimal Effect on Heart Rhythm ... Changes in Schizophrenia Patients, ... a psychopharmacologic agent being developed by Organon -- is effective,in treating ... Phase III clinical studies, were presented this week at,the 20th European ...
... first time theoretical modeling has provided a glimpse into ... something which may affect the performance of advanced electronic ... the 12th October in Physical Review Letters by researchers ... company in Austin, Texas. , Through the constant quest ...
Other Biology Technology:MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Company's Scientific Advisory Board 2MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Company's Scientific Advisory Board 3MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Company's Scientific Advisory Board 4MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Company's Scientific Advisory Board 5Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 2Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 3Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 4Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 5Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 6Novel gate dielectric materials: perfection is not enough 2
(Date:12/13/2009)... to engineer plants that take advantage of elevated carbon ... help to engineer crops that take advantage of rising ... they need for photosynthesis through microscopic breathing pores in ... the gas gained, they lose hundreds of water molecules ... save water when CO 2 is abundant, but ...
(Date:12/13/2009)... LA JOLLA, CADecember 10, 2009Researchers at The Scripps ... how a single protein from an ancient family ... in the body. In addition to providing guidance ... research supplies a theoretical underpinning for the protein,s ... macular degeneration. , The research was published in ...
(Date:12/11/2009)... understand that green plants photosynthesize, absorb carbon dioxide ... global-scale effects that photosynthesis has had on Earth. ... origins and evolution of photosynthesis is Jeffrey Touchman, ... Life Sciences. , Oxygen, one of the by-products ... their descendants (including algae and higher plants), transformed ...
Breaking Biology News(10 mins):Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3'Extreme' genes shed light on origins of photosynthesis 2'Extreme' genes shed light on origins of photosynthesis 3Bad Mood May Make Pain Worse 61304 1Bad Mood May Make Pain Worse 61304 2The Pill May Reduce Asthma Symptoms 61302 1The Pill May Reduce Asthma Symptoms 61302 2The Pill May Reduce Asthma Symptoms 61302 3Registered Nurses at St Joseph Medical Center Hold Informational Picket During Stalled Contract Negotiations 61300 1Registered Nurses at St Joseph Medical Center Hold Informational Picket During Stalled Contract Negotiations 61300 2Registered Nurses at St Joseph Medical Center Hold Informational Picket During Stalled Contract Negotiations 61300 3
... Marine Life-affiliated scientists consolidating world databases of ocean ... of all names culled from 34 regional and ... of Marine Species ( www.marinespecies.org ) contains about ... and tidied up some 56,400 aliases 32% ...
... growing up in Brooklyn, NY, UC Riverside,s Jerome Schultz ... to peer into a microscope to examine slides of tissues ... years, that early interest in science evolved into an illustrious ... that the American Institute of Chemical Engineers ( AIChE ...
... medical researchers indicate that naturally occurring nanotubes may serve ... from diseased to healthy cells a fact that ... , To better study the missions of ... form them quickly and easily in test tubes. ...
Other Biology News:Census of Marine Life lists 122,500 known species, over halfway to complete inventory by Oct. 2010 2Census of Marine Life lists 122,500 known species, over halfway to complete inventory by Oct. 2010 3Census of Marine Life lists 122,500 known species, over halfway to complete inventory by Oct. 2010 4Census of Marine Life lists 122,500 known species, over halfway to complete inventory by Oct. 2010 5UC Riverside bioengineer receives high honor from chemical engineers 2UC Riverside bioengineer receives high honor from chemical engineers 3UC Riverside bioengineer receives high honor from chemical engineers 4Nanotubes could help study retrovirus transmission between human cells 2Nanotubes could help study retrovirus transmission between human cells 3
... is tailored to highly enrich ... of non-human primate (Rhesus monkey) ... the StemSep compatible 0.5 Tesla) ... CD4+ T cell content of ...
Mol wt: monoisotopic mol wt1,045.5423 Da by calculation...
...
... Enhancing signals in immunostaining ,This solution ... and allows to get clearer signal than ... can reduce the amount of secondary antibody ... system, accordingly you can have images with ...
Biology Products: